IBA and New Mexico Cancer Center sign contract to install a Proteus®ONE proton therapy solution in Albuquerque, USA

NEXT STORY
Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba® (isavuconazole) in China
PREV STORY
Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma

author_avatar
NASDAQ Market News

HOOKIPA Announces First Patient Enrolled in Phase 2 Trial Evaluating HB-200 and Pembrolizumab for Treatment of Head and Neck Cancer and Reports FDA’s Fast Track Designation

author_avatar
NASDAQ Market News

TESARO Joins OCRFA as Presenting Sponsor of the 2017 Ovarian Cancer National Conference

WALTHAM, Mass., June 29, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News